Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types.
Nadia TerranovaMendel JansenMartin FalkBart S HendriksPublished in: Cancer chemotherapy and pharmacology (2020)
NCT02157792, EudraCT 2013-005100-34.